Serum Tumor Markers for Muscle-Invasive Bladder Cancer in Clinical Practice: A Narrative Review

被引：1
作者：
Doshi, Chirag [1 ]
Zahir, Mazyar [1 ]
Dadabhoy, Anosh [1 ]
Escobar, Domenique [1 ]
Xia, Leilei [1 ]
Daneshmand, Siamak [1 ]
机构：
[1] Univ Southern Calif, Catherine & Joseph Aresty Dept Urol, 1441 Eastlake Ave NOR 7416, Los Angeles, CA 90089 USA
来源：
CANCERS | 2025年 / 17卷 / 05期
关键词：
urothelial carcinoma; serum tumor markers; muscle-invasive bladder cancer; TRANSITIONAL-CELL CARCINOMA; CA19-9; CEA; CHEMOTHERAPY; SURVIVAL; CA-125;
D O I：
10.3390/cancers17050728
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In recent decades, serum tumor markers (STMs) have emerged as valuable adjuncts in early cancer detection and post-treatment surveillance. STMs are inexpensive, minimally invasive, and readily accessible tools that can be used to diagnose cancers, monitor patients' responses to treatment, and even detect recurrence without imposing additional burdens on patients. Emerging evidence has demonstrated the reliability of STMs in the prognostication of bladder cancer (BC). However, their potential role extends beyond prognostication. This review intends to provide a multidimensional picture of STM applications in muscle-invasive bladder cancer (MIBC). In addition, we supplement this review with real-life clinical experiences from our institution to further illustrate the clinical feasibility of STMs in MIBC.
引用
收藏
页数：11
相关论文
共 30 条
[1]   Targeting Signaling Transduction Pathways in Bladder Cancer [J].
Abbosh, Phillip H. ;
McConkey, David J. ;
Plimack, Elizabeth R. .
CURRENT ONCOLOGY REPORTS, 2015, 17 (12)
[2]   Role of CA 125, CA19-9 and CEA in predicting outcome following neoadjuvant chemotherapy in muscle invasive bladder cancer [J].
Ahmadi, H. ;
Ladi-Seyedian, S. ;
Nguyen, C. ;
Raddy, S. ;
Bhanvadia, S. ;
Djaladat, H. ;
Schuckman, A. ;
Daneshmand, S. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) :903-903
[3]   Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: Prognostic value in invasive urothelial carcinoma of the bladder [J].
Ahmadi, Hamed ;
Djaladat, Hooman ;
Cai, Jie ;
Miranda, Gus ;
Daneshmand, Siarnak .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (05) :648-656
[4]   Association between precystectomy epithelial tumor marker response to neoadjuvant chemotherapy and oncological outcomes in urothelial bladder cancer [J].
Bazargani, Soroush T. ;
Clifford, Thomas G. ;
Djaladat, Hooman ;
Schuckman, Anne K. ;
Wayne, Kevin ;
Miranda, Gus ;
Cai, Jie ;
Sadeghi, Sarmad ;
Dorff, Tanya ;
Quinn, David I. ;
Daneshmand, Siamak .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (01) :1-11
[5]   Usefulness of CA 125 as a preoperative prognostic marker for transitional cell carcinoma of the bladder [J].
Chang, A ;
Cai, J ;
Miranda, G ;
Groshen, S ;
Skinner, D ;
Stein, JP .
JOURNAL OF UROLOGY, 2004, 172 (06) :2182-2186
[6]   Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments [J].
Chung, Woonbok ;
Bondaruk, Jolanta ;
Jelinek, Jaroslav ;
Lotan, Yair ;
Liang, Shoudan ;
Czerniak, Bogdan ;
Issa, Jean-Pierre J. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (07) :1483-1491
[7]   Molecular markers of systemic therapy response in urothelial carcinoma [J].
Claps, Francesco ;
Mir, Maria Carmen ;
Zargar, Homayoun .
ASIAN JOURNAL OF UROLOGY, 2021, 8 (04) :376-390
[8]  
Cook AM, 2000, BRIT J CANCER, V82, P1952
[9]   Circulating tumor DNA as a Predictive and Prognostic Biomarker in the Perioperative Treatment of Muscle-invasive Bladder Cancer: A Systematic Review [J].
Crupi, Emanuele ;
de Padua, Tiago Costa ;
Marandino, Laura ;
Raggi, Daniele ;
Dyrskjot, Lars ;
Spiess, Philippe E. ;
Sonpavde, Guru P. ;
Kamat, Ashish M. ;
Necchi, Andrea .
EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (01) :44-52
[10]   Circulating tumor DNA: current challenges for clinical utility [J].
Dang, Donna K. ;
Park, Ben H. .
JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (12)
123